Navigation Links
UI licensee Optherion secures $37 million in financing
Date:10/9/2007

Optherion, Inc., a University of Iowa Research Foundation licensee and a company developing products to diagnose and treat age-related macular degeneration (AMD) and other chronic diseases, today announced that it has completed $37 million startup financing.

The company, which has offices and laboratories in New Haven, Conn., will expand into new facilities at the UI's Oakdale Research Park in Coralville this fall.

Optherion (http://www.optherion.com) will pursue advanced treatments and diagnostics for AMD and other diseases using core technology licensed from the UI Research Foundation. The company was founded based on scientific discoveries by Gregory Hageman, Ph.D., UI professor of ophthalmology and visual sciences, and Josephine Hoh, Ph.D., at Yale University.

In 2005, Hageman and researchers at Columbia University, the National Institutes of Health, and other institutions reported that two genes involved in controlling inflammation -- complement factor H and complement factor B -- account for nearly three out of four cases of AMD. Variations in these two genes alter the function of a key pathway in the immune system (called the alternative complement system) which researchers believe leads to AMD.

"Without question, the research discoveries by Dr. Hageman and his collaborators have been major steps in advancing our understanding of this debilitating disease," said Jean Robillard, UI vice president for medical affairs and dean of the UI Carver College of Medicine. "Now, with this collaboration between the University of Iowa and Optherion becoming a reality, we are uniquely positioned to pursue treatments that address the needs of AMD patients everywhere."

Meredith Hay, UI vice president for research, emphasized the statewide effort that made Optherion's expansion in Iowa a reality. "We are delighted that Professor Hageman's research has contributed to Optherion's growth a
'/>"/>

Contact: David Pedersen
david-pedersen@uiowa.edu
319-335-8032
University of Iowa
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Drug May Make Breathing Easier for Millions
2. Hundred million dollar gift for malaria institute
3. George Bush pledges 200 million dollars for AIDS relief
4. Hope for 11 million children facing death from illnesses
5. The forgotten epidemic killing millions
6. WHO and UNAIDS unveil plan to get 3 million AIDS patients on treatment by 2005
7. Over Six Million HIV Infected People In South Africa- Finds A Survey
8. Tanzanian Government Sanctions $20 Million For AIDS Arug
9. Grant of $7 million for Orissa Medical College from Japan
10. Merck to pay $ 253.5 million to Vioxx victim family
11. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...eClaim Revenue Gateway Alleviates Insurance Claim ...roviders , , ATLANTA, Dec. 2 /PRNewswire-Fi...day announced a new healthcare receivables solutio...s well as hospitals. SunTrust eClaim Revenue Gatew...issions as well as payment collection and processi...
(Date:12/2/2008)...o., Dec. 2 MicroPhage, Inc., htt... M. Taussig, MD has joined,the company,s Board of...onal,Jewish Medical and Research Center in Denver...espiratory diseases, from 1993 to 2006. His medic...I have followed MicroPhage extensively and am impr...
(Date:12/2/2008)...s Missing Opportunities to Connect - , , - ...escription Drug Abuse Dangers - , , NEW YOR...Partnership for a Drug-Free America and MetLife Fo...ail or text messaging to communicate with their t...nect with their kids about drug and alcohol use. T...
(Date:12/2/2008)...OCKVILLE, Md., Dec. 2 F...iods and increased supervision of work hour limits...nment, according to a new Institute of Medicine re... and Quality. , , The report is the result...ewed the relationship between residents, work sche...
Breaking Medicine News(10 mins):Health News:Healthcare Providers Now Able to Perform Real-Time Patient Eligibility Verification 2Health News:Healthcare Providers Now Able to Perform Real-Time Patient Eligibility Verification 3Health News:Healthcare Providers Now Able to Perform Real-Time Patient Eligibility Verification 4Health News:MicroPhage Selects Lynn Taussig, MD for Board of Directors 2Health News:Bridging the Technology Gap: Study Confirms Teens Open to Discussing Drugs and Alcohol With Parents By Email, Cell Phones 2Health News:Bridging the Technology Gap: Study Confirms Teens Open to Discussing Drugs and Alcohol With Parents By Email, Cell Phones 3Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 2Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 3Health News:New Report Recommends Strategies to Reduce Medical Resident Fatigue-Related Errors and Improve Training 4
...n with prostate cancer who receive a common medica...uce // the risk of recurrence after surgery may be...he research showed men treated with androgen depri...er run a higher risk of developing the bone-thinni...
... might benefit from the implantation of cardiac pa...t the conclusion // after studying 20 patients wit...currence of interrupted heart rhythm during seizur...ring seizures might be responsible for the higher ...
...e drug rolipram in mice shows promise for possible...say researchers according to a new study. Alzheime... the elderly with typical symptoms being memory lo... changes. The main factor in the cause of AD is th...
...vaginal birth after first delivering a child via c...r newborns at risk,// say researchers based on fin... anything will go wrong is extremely small, uterin...n due to lack of oxygen (hypoxic-ischemic encephal...
Other Medicine News:
(Date:12/1/2008)...ARD, Denmark, December 1 ...with the intent to procure an MVA-based,third ge...ment Services,Canada, on behalf of the Canadian D...ract to Bavarian Nordic for the delivery of IMVAMU... use IMVAMUNE(R) as part of the,country,s bio-pre...
(Date:11/30/2008)...ec. 1 Abnormalities in ...in children with autism spectrum disorder by using...y presented today at the annual meeting of the Rad..., "Using MEG, we can record the tiny magnetic fi...aid Timothy Roberts, Ph.D., vice chair of research...
(Date:11/26/2008)...information density, automation and intelligent cl...trasound to an all new level , , CHICAGO, I...Healthcare ( www.siemens.com/healthcare ) highli...Scanner (ABVS)(1), the world,s first multi-use, a...4th Scientific Assembly and Annual Meeting of the ...
(Date:11/25/2008)...FRANCISCO, Calif., Nov. 25 Proteol...nt of novel therapeutics that target,protein degr..., today,announced that data from two ongoing Phas...eloma will be presented at the upcoming 50th Annua...ASH). Carfilzomib is the first in a new class,of...
Breaking Medicine Technology:The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Ohio Company to Debut Turnkey Marketing Material During Florida National Dental Convention 20824 1Ohio Company to Debut Turnkey Marketing Material During Florida National Dental Convention 20824 2Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen Deprivation Therapy 2287 1Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen Deprivation Therapy 2287 2Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen Deprivation Therapy 2287 3Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen Deprivation Therapy 2287 4Bamboo instant houses will soon shelter Sichuan quake victims 3504 1Bamboo instant houses will soon shelter Sichuan quake victims 3504 2Is tap water safe for expectant mothers 3F 20821 1Is tap water safe for expectant mothers 3F 20821 2
...therapeutic approach for the treatment,of early an... 2007 /PRNewswire-FirstCall/ - AEterna,Zentaris In...,focused on endocrine therapy and oncology, today ...ts growth hormone-releasing,hormone (GHRH) antagon...ciation for Cancer Research (AACR) Annual Meeting ...
...pr 16, 2007 - Arsenic, a naturally,occurring eleme...r,2,000 years, and even now remains a venerable co..., Today, due in measure to the efforts of investig...ancer Research Foundation,s,(SWCRF) "Institute Wit...ed in therapy for the treatment of certain types o...
Other Medicine Technology:AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 3Research Supported by Samuel Waxman Cancer Research Foundation,Discovers Mode of Action of Arsenic-Based Drugs in Destroying,Cancer Cells 2Research Supported by Samuel Waxman Cancer Research Foundation,Discovers Mode of Action of Arsenic-Based Drugs in Destroying,Cancer Cells 3
For determination of HDL-cholesterol in serum and plasma. For Hitachi 717. Specific immunochemical inhibition of non-HDL-lipoproteins. Excellent correlation with established reference methods. Endpoi
Cholesterol/HDL Standard 50 mg/dl.
Intended for the in vitro precipitation of very low density and low density lipoproteins in serum or plasma. Single vial, dry powder precipitating reagent. Total cholesterol reagent not included.
Ready to use liquid single reagent for automated chemistry analyzers. Linearity to 1000 mmol/L
Medicine Products: